KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 118 filers reported holding KRYSTAL BIOTECH INC in Q1 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,467,000 | -10.6% | 37,070 | -6.0% | 0.00% | 0.0% |
| Q4 2021 | $2,759,000 | +792.9% | 39,447 | +566.1% | 0.00% | – |
| Q3 2021 | $309,000 | -39.4% | 5,922 | -21.1% | 0.00% | – |
| Q2 2021 | $510,000 | -6.9% | 7,501 | +5.5% | 0.00% | – |
| Q1 2021 | $548,000 | +150.2% | 7,113 | +39.9% | 0.00% | – |
| Q3 2020 | $219,000 | -73.1% | 5,083 | -73.0% | 0.00% | -100.0% |
| Q1 2020 | $815,000 | -32.1% | 18,849 | -13.0% | 0.00% | 0.0% |
| Q4 2019 | $1,200,000 | +34.4% | 21,672 | -15.7% | 0.00% | 0.0% |
| Q3 2019 | $893,000 | -26.9% | 25,713 | -15.2% | 0.00% | 0.0% |
| Q2 2019 | $1,222,000 | – | 30,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |